Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging therapeutic targets in multiple sclerosis.

Paulo Fontoura1, Lawrence Steinman, Ariel Miller

  • 1Department of Immunology, Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.

Current Opinion in Neurology
|May 17, 2006
PubMed
Summary

Recent advancements in understanding multiple sclerosis pathogenesis reveal new immune targets for developing novel immunotherapies. Personalized treatment strategies are emerging based on disease subtypes and biomarkers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study.

Scientific reports·2026
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics.

Cellular and molecular neurobiology·2026
Same author

Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments.

International journal of molecular sciences·2026
Same author

Why Is MS a More Frequent Complication of EBV Infection in Females?

Immunological reviews·2026

Area of Science:

  • Neuroimmunology
  • Genetics
  • Proteomics

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Current understanding of MS pathogenesis involves complex immune system dysregulation.
  • Identifying distinct immunopathological subtypes is crucial for effective treatment.

Purpose of the Study:

  • To review recent findings on multiple sclerosis pathogenesis.
  • To explore the translation of these findings into new therapeutic strategies.
  • To highlight advancements in personalized medicine for MS.

Main Methods:

  • Review of current literature on MS pathogenesis.
  • Analysis of immunological and molecular mechanisms.
  • Integration of findings from basic research and clinical studies.

Related Experiment Videos

  • Application of genomics and proteomics technologies.

    • Main Results:

    • New insights into immune elements in MS pathogenesis, both in the periphery and CNS.
    • Identification of molecular targets for novel immunotherapeutic strategies.
    • Evidence supporting distinct immunopathological disease subtypes requiring tailored therapies.
    • Foundation for developing neuroprotective and repair-promoting strategies.

    Conclusions:

    • Genomics and proteomics enhance understanding of MS susceptibility and progression.
    • Biomarkers are identified for disease activity and therapy response.
    • New therapeutic targets are being identified for personalized MS treatment.